Drug comparisons
Canagliflozin vs Nateglinide
Compare Canagliflozin (Invokana) SGLT2 inhibitor and Nateglinide meglitinide for type 2 diabetes, focusing on kidney glucose excretion versus pancreatic insulin stimulation.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing between an SGLT2 inhibitor and a meglitinide for type 2 diabetes based on insulin secretion needs versus glucose excretion.
Bottom line
Canagliflozin and Nateglinide offer distinct mechanisms for type 2 diabetes control with neither universally superior.
All medication comparisons